Health-e-Child PMT Paris

Tuesday 15 May 2007, 08:00 → 18:00 Europe/Zurich

Paris

agenda Agenda_Paris150507_PMT_meeting_(2).doc

Dear All, Speaking with Alessandra Martini, I was asked about our developments on the Exploitation Plan. I told her that we would be ready to introduce some first elements into our Plan for Using and Disseminating the Knowledge, which is due to be delivered by the end of June. So far nothing really significant had been told neither in our DoWs, nor in the Dissemination Strategy Plan, concerning the exploitation plan of HeC, and I would like to remind you of the comments issued at the end of the EC revue on this important issue: “There is a clear potential exploitation for this project, although the commercial prospects have not been clearly developed in the current DoW. Most of the exploitation is oriented towards dissemination and potential benefits for health and health care systems. A more targeted exploitation plan should be considered to fully exploit the likely results of the project.” These comments were followed by more general remarks on the whole of the dissemination strategy, which we should also be fully aware of: “The plan has been drafted, although it is more a collection of potential options than actual planning with a clear communication strategy behind it. The consortium is requested to re-visit the planning and to design a more concrete planning, including identification of targeted audiences, dissemination instruments and dates. It has also to be more comprehensive in geographical terms. There are only two partners involved in the dissemination, both from the same country. Other partners, from different countries, should be involved in this important activity.” The Guidelines to reporting in FP6 indicate that we “should provide an overview, per exploitable result, of how the knowledge could be exploited or used in further research (if relevant). This should be created by the project coordinator obtaining input from each contractor that owns the knowledge and has an active role in its exploitation.” The Guidelines contain also an Overview table, showing some generic examples of how it should be filled in: Exploitable Knowledge (description) Exploitable product(s) or measure(s) Sector(s) of application Timetable for commercial use Patents or other IPR protection Owner & Other Partner(s) involved 1. New superconductive Nb-Ti alloy MRI equipment 1. Medical 2. Industrial inspection 2008 2007 A materials patent is planned for 2006 Partic. X (owner) Partic. Y, Partic. Z, Poss. licensing to equipment manuf. xyz Even though our project is still at a relatively early stage concerning exploitation developments, I do not think that we can go on postponing starting to tackle this issue. Some restructuring of our efforts, in order to take into account the recommendation of involving also “other partners, from different countries”, should be included into next DoW III. All this “important activity”, as the EC reviewers qualified it, should now go beyond the simple dissemination strategy (which certainly still needs to be improved, enlarged and better specified), and include also a growing commitment to provide an analysis and definition of current or potential exploitation objectives. I also attach a first draft of the updated version of the Self Assessment Plan. I look forward to meeting you in Paris, or at least to speaking with you over the phone during the meeting, if you cannot attend. Please make use, in this latter case, of the two telephone “windows of opportunity” (at 12:00, or at 15:00) which were announced in the last email sent by Antonella. I would very much appreciate if those who cannot attend could kindly let us know in advance at what time they would prefer to join the meeting over the phone. Kind regards Edwin ___________________________ Edwin Morley-Fletcher Presidente Lynkeus srl Via Livenza 6 Roma 00198 Tel. +39 06 844 0801 Cell. +39 348 38 03 720 Fax +39 06 853 44 833 Website www.lynkeus.com * * * This email is confidential and its content may be privileged or proprietary. It may be read, copied and used only by the intended recipient. If you have received it in error, please contact the sender immediately by return email.